-
Language And Cognitive Impairment In Parkinson's Disease
This study is designed to determine the changes in the brain that occur during conditions of verbal stimulation in patients ...
Exact
-
Conceptual Processing in Alzheimer’s Disease
The purpose of this study is to evaluate memory, language and cognitive difficulties in patients with AD. AD is a ...
Exact
-
Healthy Patterns Sleep Intervention for Persons with Memory and Sleep Problems and their Caregivers
The Healthy Patterns Study intervention is a home-based activity intervention designed to introduce activities and education that promote healthy sleeping ...Exact
Phase 
-
Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) Protocol
The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease ...Exact
-
Evaluating Time Out: An Intergenerational Respite, Training and Mentorship Program
The research study is being conducted to find out if Time Out, a respite program, is helpful to families living ...
Exact
-
Development of a Goal-Directed Behavior App: Changing Apathy into Action in Neurodegenerative Disease
This is a study about creating a new mobile phone app to help people with behavioral variant Frontotemporal Degeneration (bvFTD ...
Exact
Phase 
-
Chronic insomnia and CSF markers of dementia - Phase 2
The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and ...
Exact
-
A randomized double-blind placebo-controlled parallel group study to evaluate the efficacy and safety of CNP520 in participants at risk for ...
The study will enroll cognitively unimpaired individuals who are between the ages of 60-75 years with at least one APOE4 ...
Exact
Phase
-
Phase II Study to Assess the Safety Tolerability and Target Engagement of AMX0035 a Fixed Combination of Sodium Phenylbutyrate and ...
This is a double blind, randomized, placebo controlled trial in subjects with mild cognitive impairment or dementia due to Alzheimer ...
Exact
Phase
-
18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimers Disease
BAN2401-G000-301 (Study 301) is an 18-month treatment (Core Study), multicenter, double-blind, placebo-controlled, parallel-group study in subjects with EAD (mild cognitive ...
Exact
Phase
Showing - of trials